slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 21,361-21,390
Pages 885
Rows per page 30
Arc
21,361-21,390 of 26,550
27
The slide includes experimental design details and statistical significance markers (p < 0.05).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
28
Includes survival curve (Kaplan-Meier) and pharmacodynamic response (tHcy levels over time).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
29
Includes histological images of liver tissue and a dot plot showing bone mineral density (BMD) improvement.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
30
The table displays mean/SD, range, and counts/percentages for Pegzilarginase (n=21), Placebo (n=11), and Overall (N=32).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
31
Data includes Plasma Arginine, GMFCS level, GMFM-E, and 2MWT metrics.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
32
The chart is a box-and-whisker plot showing longitudinal data from baseline through 56 weeks.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
33
Includes both continuous mean change data and categorical responder analysis.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
34
Includes a study design timeline at the bottom right and MCID reference lines on the GMFM-E chart.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
35
Slide details GMFCS classification levels and GMFM/Timed Walk Test methodologies.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
36
The slide uses a process flow diagram to illustrate the clinical trial structure.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
37
The slide highlights clinical response in specific patients, emphasizing normalization of mobility metrics.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
38
The slide uses a split-screen layout: left side is market sizing/geographic distribution, right side is a 2x2 matrix of launch activities.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
04
The slide uses a hierarchical structure to connect a high-level objective to three specific strategic pillars.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Beat · Solution1 hit
05
The slide uses a Gantt-style visualization to represent drug development stages.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Beat · Business Model1 hit
07
The slide uses a combination of a map-based infographic and a vertical process/timeline-style list to illustrate the severity of the condition.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
Uses a combination of bubble charts for categories and a vertical list for key metrics.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
04
Uses a series of four callout boxes to present key statistics regarding food demand and environmental impact.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
The diagram uses a hand-drawn style to map inputs (genetics) to outputs (market segments) via a central 'Partners' hub.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · AgitateLoop · Golden Circle1 hit
07
Uses a five-column layout with circular imagery to represent distinct product development pillars.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a hub-and-spoke style layout to show market segments.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a horizontal arrow timeline graphic to represent the 2023-2025 period.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a horizontal arrow timeline to frame three distinct strategic initiatives.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a timeline-like arrow pointing to 'Beyond 2028' to frame the strategic initiatives.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Benson Hill | Results Presentation Deck | 23 slidesBenson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Includes adjustments for open mark-to-market timing differences and excludes Fresh Business.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · Desire1 hit
14
The table highlights the impact of a Liquidity Improvement Plan on OPEX, EBITDA, and Free Cash Flow.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · Desire1 hit
15
Benson Hill | Results Presentation Deck | 23 slidesBenson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · Desire1 hit
16
Benson Hill | Results Presentation Deck | 23 slidesBenson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
01
Cano Health | Investor Presentation Deck | 48 slidesCano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations Beat · Setup1 hit
02
Cano Health | Investor Presentation Deck | 48 slidesCano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations Beat · Setup1 hit